Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Krognes Steve E. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Krognes Steve E. (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Exercised 155 restricted stock units @ $0
08/23/2023 4 Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 1,419 shares @ $22.6, valued at $32.1k
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 Krognes Steve E. (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Exercised 1,851 restricted stock units @ $0
06/16/2023 4 Krognes Steve E. (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Granted 8,803 options to buy @ $38.005, valued at $334.6k
Granted 5,592 restricted stock units @ $0
06/05/2023 4 Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 4,216 shares @ $0
Granted 12,649 options to buy @ $30.92, valued at $391.1k
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 2,970 shares @ $28.44, valued at $84.5k
08/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2022 4 Krognes Steve E. (Director) has filed a Form 4 on Guardant Health, Inc.
Txns: Granted 7,405 restricted stock units @ $0
Granted 11,879 options to buy @ $48.96, valued at $581.6k
07/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2022 3 Krognes Steve E. (Director) has filed a Form 3 on Guardant Health, Inc.
06/22/2022 4 Krognes Steve E. (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 19,000 options to buy @ $2.22, valued at $42.2k
02/15/2022 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 2,560 shares @ $34.69, valued at $88.8k
02/11/2022 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 1,296 shares @ $37.0931, valued at $48.1k
01/07/2022 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 2,225 shares @ $44.75, valued at $99.6k
01/05/2022 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 31,000 shares @ $0
Granted 93,000 options to buy @ $47.27, valued at $4.4M
11/19/2021 4 Krognes Steve E. (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 19,000 options to buy @ $9.86, valued at $187.3k
08/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 2,635 shares @ $70.174, valued at $184.9k
Sold 400 shares @ $71.428, valued at $28.6k
02/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 14,801 shares @ $70.099, valued at $1M
Sold 12,981 shares @ $70.962, valued at $921.2k
Sold 8,071 shares @ $71.992, valued at $581k
Sold 14,147 shares @ $73.006, valued at $1M
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/24/2020 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Exercised 5,643 shares @ $0
Paid exercise price by delivering 1,954 shares @ $32.87, valued at $64.2k
Exercised 5,643 restricted stock units @ $0
08/20/2020 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 20,000 restricted stock units @ $0
06/22/2020 4 Krognes Steve E. (Director) has filed a Form 4 on Gritstone Oncology, Inc.
Txns: Granted 12,500 options to buy @ $6.66, valued at $83.3k
06/12/2020 4 Krognes Steve E. (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $3.27, valued at $49.1k
04/01/2020 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 1,428 shares @ $19.48, valued at $27.8k
04/01/2020 4/A Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Exercised 4,250 restricted stock units @ $0
03/23/2020 4 Krognes Steve E. (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $2, valued at $30k
02/12/2020 4 Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 29,143 restricted stock units @ $0
Granted 136,000 options to buy @ $24.81, valued at $3.4M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy